Delivery Order SPE2DB20D2104-SPE2DB26FMAKN
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,945.28 on June 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL). The contract operates under a firm fixed-price structure with no set-aside designation, indicating competitive award. Performance will be fulfilled from the company's Conshohocken, Pennsylvania location, with an ultimate completion date of June 5, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,237.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen auto-injectors (0.5 mL units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectors valued at $2,131.26. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 10, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,380.90 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 26, 2025, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and specifies performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $7,142.61 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,334.91 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by October 20, 2025. AmerisourceBergen Drug Corp will perform from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.04 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 30, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $14,658.18. This is a firm fixed price delivery order with a completion date of September 30, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $5,387.02 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This firm fixed-price, non-set-aside contract will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 21, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAKNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,927.84 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL dosage) on October 20, 2025, with completion scheduled for October 21, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through multiple competitively awarded contracts with the Defense Logistics Agency. The company's federal contract portfolio demonstrates significant capability in delivering brand-name and generic medications across multiple therapeutic domains, including diabetes treatments like Trulicity. As a prime contractor under the DLA Troop Support Medical program, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with anticipated expansion under planned Pharmaceutical Prime Vendor Global Program Generation V regional contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/20/25 |